Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NVT vs GSK✓SelectedUSD · GSKNVT vs GSK performance historyLatest closeAs of-0.22%11/17
Stock and ETF performance explorer

NVT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-33.6%
GSK return
-2.1%
Excess return
-31.4%
Maximum drawdown
-43.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.2%-2.3%+2.1%-3.1%
7D-2.9%-3.0%+0.1%-6.6%
30D-23.0%+0.4%-23.3%-20.8%
All-33.6%-2.1%-31.4%-33.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3mo analysis · Full analysis span regression · Available span rolling